donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > CNMD ConMed > Key Indicators
CNMD ConMed
95.760
-4.240-4.24%
Post Mkt Price
95.76000.00%
YOY
Do not show
Hide blank lines
(Q1)2022/03/31(FY)2021/12/31(Q4)2021/12/31(Q3)2021/09/30
Financial Ratios
Efficiency Ratios TTM
Cash Conversion Cycle(D)
7.05% 200.1113 2.11% 195.0836 2.11% 195.0836 2.08% 188.2395
Receivable Turnover(T)
10.21% 5.8772 18.87% 5.5986 18.87% 5.5986 15.82% 5.9603
Inventory Turnover(T)
-10.56% 1.9355 -7.24% 2.0754 -7.24% 2.0754 -6.05% 2.1486
Fixed Assets Turnover(T)
18.83% 9.3645 22.51% 9.1763 22.51% 9.1763 17.01% 8.9371
Total Asset Rate(T)
14.65% 0.5777 17.48% 0.5746 17.48% 0.5746 13.29% 0.5659
ROIC
100.03% 6.241% 123.61% 6.288% 123.61% 6.288% 186.84% 6.190%
ROE
373.84% 8.931% 524.19% 8.370% 524.19% 8.370% 19167.71% 8.651%
ROA
398.08% 3.831% 558.87% 3.556% 558.87% 3.556% 19896.07% 3.559%
FCF to Sales
-8.13% 7.283% 60.52% 9.588% 60.52% 9.588% 6.38% 8.419%
FCF to Net Income
-78.85% 109.833% -71.38% 154.942% -71.38% 154.942% -99.4% 133.846%
Efficiency Ratios
ROE 5 Year Average
-- -- 24.91% 5.871% -- -- -- --
ROA 5 Year Average
-- -- 22.04% 2.609% -- -- -- --
Average 5 Years ROIC
-- -- 16.28% 5.101% -- -- -- --
Profitability Ratios TTM
Gross Margin
5.85% 56.414% 5.31% 56.206% 5.31% 56.206% 3.7% 55.351%
Operating Margin
82.9% 10.985% 103.5% 10.856% 103.5% 10.856% 74.64% 9.823%
Net Margin
334.41% 6.631% 460.8% 6.188% 460.8% 6.188% 17568.26% 6.290%
EBITDA Margin
24.4% 0.1767% 29.39% 0.1774% 29.39% 0.1774% 20.74% 0.1691%
R & D Expense Ratio
-5.46% 4.330% -8.1% 4.310% -8.1% 4.310% -4.93% 4.440%
Sales Expense Ratio
-- 0.000% -- 0.000% -- 0.000% -- 0.000%
Administration Expense Rate
-- 0.000% -- 0.000% -- 0.000% -- 0.000%
Financial Health Ratios
Long-Term Debt to Equity Ratio
-10.86% 89.107% -19.06% 85.610% -19.06% 85.610% -16.39% 93.073%
Total Assets to Common Equity
-6.05% 226.171% -8.99% 224.846% -8.99% 224.846% -9.03% 232.120%
Debt to Asset Ratio
-11.75% 90.656% -20.34% 87.169% -20.34% 87.169% -16.77% 94.694%
Current Ratio
11.73% 2.6029 6.81% 2.3399 6.81% 2.3399 7.21% 2.4204
Quick Ratio
0.67% 1.1094 -3.17% 1.0411 -3.17% 1.0411 -4.8% 1.0751
GrowthRatios
Growth Ratios
Revenue CAGR(3Y)
-- -- 105.88% 5.542% -- -- -- --
Revenue CAGR(5Y)
-- -- 55.87% 5.768% -- -- -- --
Net Income CAGR(3Y)
-- -- 134.32% 15.251% -- -- -- --
Net Income CAGR(5Y)
-- -- 261.97% 33.655% -- -- -- --
Dividend CAGR(3Y)
-- -- -- 0.000% -- -- -- --
Dividend CAGR(5Y)
-- -- -- 0.000% -- -- -- --
FCF 1 Year Growth
-- -- 380.83% 88.097% -- -- -- --
FCF CAGR(3Y)
-- -- 2511.57% 18.528% -- -- -- --
FCF CAGR(5Y)
-- -- 253.42% 32.791% -- -- -- --
Currency Unit
USDUSDUSDUSD

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
CEO: Hartman, Curt R.
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...